Retrieve available abstracts of 28 articles: HTML format
Single Articles
April 2025
SMELIK M, Diaz-Roncero Gonzalez D, An X, Heer R, et al Combining Spatial Transcriptomics, Pseudotime, and Machine Learning Enables
Discovery of Biomarkers for Prostate Cancer.
Cancer Res. 2025 Apr 28. doi: 10.1158/0008-5472.CAN-25-0269. PubMedAbstract available
CRUZ-HERNANDEZ CD, Smith B, Billet S, Thiruvalluvan M, et al A Cyanobacteria-derived RNA aptamer resensitizes prostate cancer to hormone
therapy.
Cancer Res. 2025 Apr 28. doi: 10.1158/0008-5472.CAN-24-4039. PubMedAbstract available
February 2025
ZHAO Y, Ramesh N, Xu P, Sei E, et al Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics
of Metastatic Prostate Cancer During Serial Therapy.
Cancer Res. 2025 Feb 24. doi: 10.1158/0008-5472.CAN-24-1943. PubMedAbstract available
ZHANG C, Ding J, Lim KS, Zhou W, et al JMJD6 Rewires ATF4-Dependent Glutathione Metabolism to Confer Ferroptosis
Resistance in SPOP-Mutated Prostate Cancer.
Cancer Res. 2025 Feb 4. doi: 10.1158/0008-5472.CAN-23-2796. PubMedAbstract available
December 2024
SIPOLA J, Munzur AD, Kwan EM, Seo CCY, et al Plasma cell-free DNA chromatin immunoprecipitation profiling depicts phenotypic
and clinical heterogeneity in advanced prostate cancer.
Cancer Res. 2024 Dec 9. doi: 10.1158/0008-5472.CAN-24-2052. PubMedAbstract available
November 2024
BAE TH, Sung KW, Pham TM, Najy AJ, et al An Autophagy-Targeting Chimera Induces Degradation of Androgen Receptor Mutants
and AR-v7 in Castration-Resistant Prostate Cancer.
Cancer Res. 2024 Nov 12. doi: 10.1158/0008-5472.CAN-24-0591. PubMedAbstract available
MCQUILLEN CN, Brady NJ ASCL1 Drives the Development of Neuroendocrine Prostate Cancer.
Cancer Res. 2024;84:3499-3501. PubMedAbstract available
October 2024
ZHANG L, Troccoli CI, Mateo-Victoriano B, Misiara Lincheta L, et al Stimulating Soluble Guanylyl Cyclase with the Clinical Agonist Riociguat
Restrains the Development and Progression of Castration-Resistant Prostate
Cancer.
Cancer Res. 2024 Oct 10. doi: 10.1158/0008-5472.CAN-24-0133. PubMedAbstract available
September 2024
RODARTE KE, Nir Heyman S, Guo L, Flores L, et al Neuroendocrine Differentiation in Prostate Cancer Requires ASCL1.
Cancer Res. 2024 Sep 12. doi: 10.1158/0008-5472.CAN-24-1388. PubMedAbstract available
August 2024
SONG H, Lu T, Han D, Zhang J, et al YAP1 Inhibition Induces Phenotype Switching of Cancer-Associated Fibroblasts to
Tumor Suppressive in Prostate Cancer.
Cancer Res. 2024 Aug 13. doi: 10.1158/0008-5472.CAN-24-0932. PubMedAbstract available
NING S, Armstrong CM, Xing E, Leslie AR, et al LX1 Targets Androgen Receptor Variants and AKR1C3 to overcome Therapy Resistance
in Advanced Prostate Cancer.
Cancer Res. 2024 Aug 1. doi: 10.1158/0008-5472.CAN-24-0440. PubMedAbstract available
July 2024
SHRESTHA R, Chesner LN, Zhang M, Zhou S, et al An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the
Epigenetic Evolution during Tumor Progression.
Cancer Res. 2024 Jul 11. doi: 10.1158/0008-5472.CAN-24-0890. PubMedAbstract available
YOO YA, Quan S, Yang W, Guo Q, et al Asparagine Dependency is a Targetable Metabolic Vulnerability in TP53-Altered
Castration-Resistant Prostate Cancer.
Cancer Res. 2024 Jul 3. doi: 10.1158/0008-5472.CAN-23-2910. PubMedAbstract available
June 2024
ZHANG W, Maeser D, Lee A, Huang Y, et al Integration of Pan-Cancer Cell Line and Single-Cell Transcriptomic Profiles
Enables Inference of Therapeutic Vulnerabilities in Heterogeneous Tumors.
Cancer Res. 2024;84:2021-2033. PubMedAbstract available
LI W, Guo F, Zeng R, Liang H, et al CDK4/6 Alters TBK1 Phosphorylation to Inhibit the STING Signaling Pathway in
Prostate Cancer.
Cancer Res. 2024 Jun 11. doi: 10.1158/0008-5472.CAN-23-3704. PubMedAbstract available
BOUFAIED N, Chetta P, Hallal T, Cacciatore S, et al Obesogenic High-Fat Diet and MYC Cooperate to Promote Lactate Accumulation and
Tumor Microenvironment Remodeling in Prostate Cancer.
Cancer Res. 2024;84:1834-1855. PubMedAbstract available
FRIGO DE Diet and Tumor Genetics Conspire to Promote Prostate Cancer Metabolism and Shape
the Tumor Microenvironment.
Cancer Res. 2024;84:1742-1744. PubMedAbstract available
GALLAGHER K, Strobl MAR, Park DS, Spoendlin FC, et al Mathematical Model-Driven Deep Learning Enables Personalized Adaptive Therapy.
Cancer Res. 2024;84:1929-1941. PubMedAbstract available
April 2024
SHRESTHA RK, Nassar ZD, Hanson AR, Iggo R, et al ACSM1 and ACSM3 regulate fatty acid metabolism to support prostate cancer growth
and constrain ferroptosis.
Cancer Res. 2024 Apr 24. doi: 10.1158/0008-5472.CAN-23-1489. PubMedAbstract available
CUNNINGHAM M, Schiewer MJ PARP-ish: Gaps in Molecular Understanding and Clinical Trials Targeting PARP
Exacerbate Racial Disparities in Prostate Cancer.
Cancer Res. 2024 Apr 18. doi: 10.1158/0008-5472.CAN-23-3458. PubMedAbstract available
MURPHY S, Rahmy S, Gan D, Liu G, et al Ketogenic diet alters the epigenetic and immune landscape of prostate cancer to
overcome resistance to immune checkpoint blockade therapy.
Cancer Res. 2024 Apr 8. doi: 10.1158/0008-5472.CAN-23-2742. PubMedAbstract available
March 2024
SHU F, Liu H, Chen X, Liu Y, et al m6A modification promotes EMT and metastasis of castration-resistant prostate
cancer by upregulating NFIB.
Cancer Res. 2024 Mar 27. doi: 10.1158/0008-5472.CAN-23-1954. PubMedAbstract available
January 2024
ZHAO J, Xu N, Zhu S, Nie L, et al Genomic and Evolutionary Characterization of Concurrent Intraductal Carcinoma and
Adenocarcinoma of the Prostate.
Cancer Res. 2024;84:154-167. PubMedAbstract available
December 2023
MISHRA R, Blinka S, Hsieh AC Citron Kinase Is a Druggable Target in Treatment-Resistant Prostate Cancer.
Cancer Res. 2023;83:4008-4009. PubMedAbstract available
AWAD D, Cao PHA, Pulliam TL, Spradlin M, et al Adipose triglyceride lipase is a therapeutic target in advanced prostate cancer
that promotes metabolic plasticity.
Cancer Res. 2023 Dec 1. doi: 10.1158/0008-5472.CAN-23-0555. PubMedAbstract available
October 2023
RAWAT C, Ben-Salem S, Singh N, Chauhan G, et al Prostate cancer progression relies on the mitotic kinase citron kinase.
Cancer Res. 2023 Oct 6. doi: 10.1158/0008-5472.CAN-23-0883. PubMedAbstract available
September 2023
LI Z, Ning K, Zhao D, Zhou Z, et al Targeting the metabolic enzyme PGAM2 overcomes enzalutamide resistance in
castration-resistant prostate cancer by inhibiting BCL2 signaling.
Cancer Res. 2023 Sep 7. doi: 10.1158/0008-5472.CAN-23-0308. PubMedAbstract available
NYQUIST MD, Coleman IM, Lucas JM, Li D, et al Supraphysiological Androgens Promote the Tumor Suppressive Activity of the
Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex.
Cancer Res. 2023;83:2938-2951. PubMedAbstract available